Where do Esperion Therapeutics's ratios come from?

Every ratio is computed from Esperion Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	15%-2.7pp	17.7%+151pp	-133.7%+104pp	-237.8%+51.2pp
Efficiency
Asset turnover	1×-0.2×	1.2×+0.7×	0.5×+0.3×	0.2×0.0×
Liquidity
Current ratio	1.5×+0.2×	1.4×+0.1×	1.3×-1.4×	2.7×-1.8×
Leverage
Net debt / EBITDA	-0.2×-0.2×	0×—	——	——
Per Share
Book value per share	-$1.45+30.0%	-$2.08+52.9%	-$4.41+9.5%	-$4.88+28.4%
Valuation
Market capitalization	$811.73M+283%	$433.48M+27.5%	$340.02M-25.9%	$459.05M+47.3%
Price / sales	1.9×+1.1×	1.3×-1.6×	2.9×-3.2×	6.1×+2.1×
EV / EBITDA	10.7×—	7.4×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Esperion Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Esperion Therapeutics's ratios come from?: Every ratio is computed from Esperion Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.